重楼作为我国一种重要的中药材，其疗效确切，具有镇痛、止血、抗炎和抗肿瘤等活性。目前为我国云南白药、宫血宁胶囊等262种中成药的主要原料，在中医药行业中具有重要的经济、社会价值。主要从重楼的药用历史及产地变迁、产业发展历史、少数民族和民间应用现状、中成药开发与应用现状和资源生态与繁育研究等方面进行系统的总结，并提出实施重楼产业化过程中需关注的重要问题及对策，以期为重楼产业的良性发展提供参考。

As an important Chinese medicinal material in China, Paridis Rhizoma has obvious curative effect and has analgesic, hemostasis, anti-inflammatory and anti-tumor activities. At present, it is the main raw material of 262 kinds of Chinese patent medicines such as Yunnan Baiyao and Gongxuening Capsule, and has important economic and social value in the Chinese medicine industry. The author mainly systematically summarizes the medicinal history and origin changes of Paridis Rhizoma, the history of industrial development, the status quo of ethnic and folk applications, the status quo of development and application of proprietary Chinese medicines, and the study of resource ecology and breeding, and proposes the implementation of the process of industrialization of Paridis Rhizoma. Important issues and countermeasures need to be paid attention in order to provide reference for the sound development of Paridis Rhizoma.

R286

国家自然科学基金资助项目（31860080）；云南省地方本科高校（部分）基础研究联合专项（2017FH-001-097）；大理州重点科技支撑专项计划（D2018SA01）；大理大学中药资源与民族药创新团队（ZKLX2019318）